GNL1 Antibodies

Santa Cruz Biotechnology provides a broad selection of GNL1 monoclonal antibodies for investigating GNL1's role in cellular processes. GNL1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GNL1, or Guanine nucleotide-binding protein-like 1, actively participates in regulating cellular growth and proliferation. GNL1 maintains essential functions in ribosome biogenesis and ensures proper nucleolus operation. Research has shown that GNL1 expression levels can vary significantly across different tissue types. Understanding GNL1 function continues to reveal important insights about its role in various diseases, including cancer. Ongoing studies focus on mapping GNL1 interactions with other cellular components to better understand its regulatory mechanisms. Current research emphasizes the importance of GNL1 in maintaining cellular homeostasis and its potential as a therapeutic target. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of GNL1's biological significance and potential therapeutic applications.